Table 2 Incidence of most commonly reported adverse events

Frovatriptan 2.5 mg QD

n=501

n=505

Nausea

4.80%

3.40%

Headache

4.60%

6.30%

Dizziness

3.60%

2.60%

Nasopharyngitis

3.20%

2.40%

Dysmenorrhea

2.20%

3.00%

Frovatriptan 2.5 mg BID

n=501

n=505

Nausea

6.80%

3.40%

Dizziness

4.80%

2.60%

Headache

4.20%

6.30%

Nasopharyngitis

3.40%

2.40%

Dysmenorrhea

1.80%

3.00%

Naratriptan 1 mg BID

n=71

n=68

Dyspeptic symptoms

4.23%

0.00%

Malaise and fatigue

1.41%

2.94%

Dizziness

1.41%

1.47%

Hyposalivation

1.41%

0.00%

Parasthesia

1.41%

0.00%

Naratriptan 2.5 mg BID

n=71

n=68

Dizziness

4.23%

1.47%

Chest symptoms

2.82%

2.94%

Malaise and fatigue

2.82%

2.94%

Hyposalivation

2.82%

0.00%

Parasthesia

2.82%

0.00%

Burning/stinging sensations

2.82%

0.00%

Zolmitriptan 2.5 mg BID

n=80

n=82

Asthenia

8.75%

9.76%

Dizziness

6.25%

4.88%

Somnolence

6.25%

3.66%

Nausea

6.25%

1.22%

Tightness

5.00%

2.44%

Headache

3.75%

2.44%

Dry mouth

1.25%

1.22%

Zolmitriptan 2.5 mg TID

n=84

n=82

Asthenia

10.71%

9.76%

Headache

8.33%

2.44%

Dizziness

7.14%

4.88%

Somnolence

7.14%

3.66%

Tightness

7.14%

2.44%

Nausea

7.14%

1.22%

Dry mouth

5.95%

1.22%